4SC AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1997-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.4sc.de
SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid Arthritis
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-11-10
- Last Posted Date
- 2012-03-01
- Lead Sponsor
- 4SC AG
- Target Recruit Count
- 266
- Registration Number
- NCT01010581
- Locations
- 🇧🇬
UMHAT "Sveti Ivan Rilski", Sofia, Bulgaria
🇵🇱Śląskie Centrum Osteoporozy, Katowice, Poland
🇵🇱Wojewódzki Szpital Reumatologiczny, Sopot, Poland
4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma
- First Posted Date
- 2009-07-22
- Last Posted Date
- 2014-01-16
- Lead Sponsor
- 4SC AG
- Target Recruit Count
- 57
- Registration Number
- NCT00943449
- Locations
- 🇮🇹
l'Azienda Ospedaliero-Universitaria di Bologna-Policlinico S. Orsola Malpighi, Bologna, Italy
🇩🇪Universitätsklinikum Hamburg-Eppendorf (I. Medizinische Klinik und Poliklinik), Hamburg, Germany
🇮🇹Istituto Europea di Oncologia EIO, Milano, Italy
SC12267 (4SC-101) for Treatment of Patients With Inflammatory Bowel Disease
Phase 2
Completed
- Conditions
- First Posted Date
- 2009-01-12
- Last Posted Date
- 2011-05-18
- Lead Sponsor
- 4SC AG
- Target Recruit Count
- 34
- Registration Number
- NCT00820365
- Locations
- 🇩🇪
Schwerpunktpraxis für chronisch entzündliche Darmerkrankungen, Hamburg, Germany
🇩🇪Universitätsklinikum Regensburg Klinik und Poliklinik für Innere Medizin I, Regensburg, Germany
🇷🇴University Emergency Hospital, Bucuresti, Romania
© Copyright 2024. All Rights Reserved by MedPath